Sage Laboratories Inc
—- Market cap
- —
- Debt
- —
- Cash
- —
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: Sage Laboratories Inc stock price vs VSH: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at VSH's multiple
Needs Revenue / share.
Implied fair value · at Sage Laboratories Inc's multiple
Needs Sage Laboratories Inc P/S.
Engine logicSage Laboratories Incvalued onVSH’smultiple
Metric by metric
Snapshot Sep 4, 4:00 PM ET
Where each company leads, and how wide the gap is.
Higher is better
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: Sage Laboratories Inc Latest annual filing · VSH FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 81% equity / 19% debt · EV / Revenue 1.50x · EV / EBITDA 18.41x
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
SAGE LABORATORIES INC · implied price per share
Reporting currency could not be verified.
Vishay Intertechnology, Inc. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Sage Laboratories Inc · not enough data.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
—
0.46x
Net debt / EBITDA
Leverage against operating earnings
—
1.74x
Cash and equivalents
Liquid reserves on the balance sheet
—
$514.97M
Total debt
Interest-bearing obligations outstanding
—
$950.89M
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
TEXAS INSTRUMENTS INC
Sage Laboratories Inc vs TXN
ANALOG DEVICES INC
Sage Laboratories Inc vs ADI
INTEL CORP
Sage Laboratories Inc vs INTC
MICROCHIP TECHNOLOGY INC
Sage Laboratories Inc vs MCHP
BEL FUSE INC /NJ
Sage Laboratories Inc vs BELFA
AMPHENOL CORP /DE/
Sage Laboratories Inc vs APH
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.